Claudia Bruedigam

2.2k citations

25 papers · 1.4k indexed · 1 hit paper · h-index 14

Co-authors: Fernando Carrari Alisdair R. Fernie Ute Roessner Yaniv Semel Ilse Balbo Tzili Pleban Joachim Kopka Dani Zamir
Topics: Acute Myeloid Leukemia Research (11 papers)Peroxisome Proliferator-Activated Receptors (5 papers)Telomeres, Telomerase, and Senescence (5 papers)
Cited by: Genetics Plant Science Hematology
Journals: Proceedings of the National Academy of Sciences Nature Communications Blood
Partner nations: Australia Germany United States

In The Last Decade

Claudia Bruedigam

25 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comprehensive metabolic profiling and phenotyping of interspecific introgression lines for tomato improvement

2006 553 citations Ute Roessner, Fernando Carrari et al. profile →

Peers

Countries citing papers authored by Claudia Bruedigam

Since Specialization

Citations

This map shows the geographic impact of Claudia Bruedigam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Bruedigam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Bruedigam more than expected).

Fields of papers citing papers by Claudia Bruedigam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Bruedigam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Bruedigam. The network helps show where Claudia Bruedigam may publish in the future.

Co-authorship network of co-authors of Claudia Bruedigam

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Bruedigam. A scholar is included among the top collaborators of Claudia Bruedigam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Bruedigam. Claudia Bruedigam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Overcoming Ven/Aza Resistance through Imetelstat-Mediated Lipophagy in Acute Myeloid Leukemia 2024 ·Blood ·Claudia Bruedigam,(unknown),(unknown),Amy H. Porter,Elaine Hsuen Lim,(unknown),Mark P. Hodson,Florian H. Heidel,Steven Lane	1
2	Modeling Acute Myeloid Leukemia Using StarPEG-Heparin Hydrogels 2024 ·Methods in molecular biology ·(unknown),Akhilandeshwari Ravichandran,(unknown),Claudia Bruedigam,Laura J. Bray	1
3	Gene Expression Analyses in Models of Rosiglitazone-Induced Physiological and Pathological Mineralization Identify Novel Targets to Improve Bone and Vascular Health 2023 ·Cells ·Claudia Bruedigam,Johannes P.T.M. van Leeuwen,Jeroen van de Peppel	2
4	Cre recombinase expression cooperates with homozygous FLT3 internal tandem duplication knockin mouse model to induce acute myeloid leukemia 2023 ·Leukemia ·Jasmin Straube,(unknown),Therese Vu,(unknown),(unknown),Björn von Eyß,Leanne Cooper,Claudia Bruedigam,Victoria Ling,Emily Cooper,Ann‐Marie Patch,Lars Bullinger,(unknown),Megan J. Bywater,Florian H. Heidel,Steven Lane	1
5	Telomerase-targeted therapies in myeloid malignancies 2023 ·Blood Advances ·(unknown),Claudia Bruedigam,Rami S. Komrokji,Catriona Jamieson,John Mascarenhas	14
6	Oncogenic drivers dictate immune control of acute myeloid leukemia 2023 ·Nature Communications ·(unknown),Jasmin Straube,(unknown),(unknown),Claudia Bruedigam,Matthew T. Witkowski,Leanne Cooper,Amy H. Porter,Matthias Braun,Fernando Souza-Fonseca-Guimarães,Simone A. Minnie,Emily Cooper,Sébastien Jacquelin,Axia Song,Tobias Bald,Kyohei Nakamura,Geoffrey R. Hill,Iannis Aifantis,Steven Lane,Megan J. Bywater	11
7	Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemia 2022 ·Leukemia ·Victoria Ling,Jasmin Straube,William Godfrey,(unknown),(unknown),Leanne Cooper,Claudia Bruedigam,Emily Cooper,(unknown),Sébastien Jacquelin,Siok‐Keen Tey,Jonathan B. Baell,Fei Huang,(unknown),Yichao Zhao,Lars Bullinger,Megan J. Bywater,Steven Lane	25
8	Analysis of telomerase target gene expression effects from murine models in patient cohorts by homology translation and random survival forest modeling 2016 ·Genomics Data ·Frederik Otzen Bagger,Claudia Bruedigam,Steven Lane	1
9	Telomerase in hematologic malignancies 2016 ·Current Opinion in Hematology ·Claudia Bruedigam,Steven Lane	17
10	NK cells require IL-28R for optimal in vivo activity 2015 ·Proceedings of the National Academy of Sciences ·Fernando Souza-Fonseca-Guimarães,Arabella Young,Deepak Mittal,Ludovic Martinet,Claudia Bruedigam,Kazuyoshi Takeda,Christopher E. Andoniou,Mariapia A. Degli‐Esposti,Geoffrey R. Hill,Mark J. Smyth	76
11	EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia 2015 ·PLoS ONE ·Sara Charmsaz,(unknown),Fiona Smith,Claudia Bruedigam,Andrew S. Moore,Fares Al‐Ejeh,Steven Lane,Andy Boyd	19
12	Autophagy is required for stem cell mobilization by G-CSF 2015 ·Blood ·Lucie Leveque,Therese Vu,Katie E. Lineburg,Rachel D. Kuns,Frederik Otzen Bagger,Bianca E. Teal,Mary Lor,Glen M. Boyle,Claudia Bruedigam,Justine D. Mintern,Geoffrey R. Hill,Kelli P. A. MacDonald,Steven Lane	36
13	Telomerase Inhibition Effectively Targets Mouse and Human AML Stem Cells and Delays Relapse following Chemotherapy 2014 ·Cell stem cell ·Claudia Bruedigam,Frederik Otzen Bagger,Florian H. Heidel,(unknown),(unknown),Axia Song,Rebecca Austin,Therese Vu,(unknown),(unknown),Andrew S. Moore,Richard B. Lock,Lars Bullinger,Geoffrey R. Hill,Scott A. Armstrong,David A. Williams,Steven Lane	61
14	Inhibition of Telomerase with Imetelstat Is Detrimental to Leukemia Stem Cells in Acute Myeloid Leukemia (AML) 2014 ·Blood ·Claudia Bruedigam,Frederik Otzen Bagger,Florian H. Heidel,(unknown),(unknown),Axia Song,Rebecca Austin,Therese Vu,Erwin M. Lee,Andrew S. Moore,Richard B. Lock,Lars Bullinger,Geoffrey R. Hill,Steven Lane	1
15	Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera 2013 ·Blood ·Ann Mullally,Claudia Bruedigam,Luke Poveromo,Florian H. Heidel,(unknown),Therese Vu,Rebecca Austin,Dirk Heckl,Lawrence J. Breyfogle,(unknown),Demetrios Kalaitzidis,Scott A. Armstrong,David A. Williams,Geoffrey R. Hill,Benjamin L. Ebert,Steven Lane	126
16	Autophagy Is Required For Long-Term Hematopoietic Stem Cell (HSC) Function and G-CSF-Induced HSC Mobilization 2013 ·Blood ·Lucie Leveque,Therese Vu,Rachel D. Kuns,Bianca E. Teal,Mary Lor,Katie E. Lineburg,Claudia Bruedigam,Frederik Otzen Bagger,Glen M. Boyle,Geoffrey R. Hill,Kelli P. A. MacDonald,Steven Lane	1
17	1α,25-Dihydroxyvitamin D3 and rosiglitazone synergistically enhance osteoblast-mediated mineralization 2012 ·Gene ·(unknown),Claudia Bruedigam,Marijke Koedam,Hideki Chiba,Bram C. J. van der Eerden,Johannes P.T.M. van Leeuwen	15
18	Opposing actions of rosiglitazone and resveratrol on mineralization in human vascular smooth muscle cells 2011 ·Journal of Molecular and Cellular Cardiology ·Claudia Bruedigam,Marco Eijken,Marijke Koedam,Hideki Chiba,Johannes P.T.M. van Leeuwen	9
19	Evidence for multiple peroxisome proliferator‐activated receptor γ transcripts in bone: Fine‐tuning by hormonal regulation and mRNA stability 2008 ·FEBS Letters ·Claudia Bruedigam,Marijke Koedam,Hideki Chiba,Marco Eijken,Johannes P.T.M. van Leeuwen	29
20	Metabolic Profiling of Transgenic Tomato Plants Overexpressing Hexokinase Reveals That the Influence of Hexose Phosphorylation Diminishes during Fruit Development 2003 ·PLANT PHYSIOLOGY ·Ute Roessner,Björn Hegemann,Anna Lytovchenko,Fernando Carrari,Claudia Bruedigam,David Granot,Alisdair R. Fernie	278

About Claudia Bruedigam

Claudia Bruedigam is a scholar working on Hematology, Genetics and Orthopedics and Sports Medicine, having authored 25 papers that have together received 1.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Telomeres, Telomerase, and Senescence (5 papers). The work is most often cited by research in Genetics (169 citations), Plant Science (571 citations) and Hematology (169 citations). Claudia Bruedigam has collaborated with scholars based in Australia, Germany and United States. Frequent co-authors include Fernando Carrari, Alisdair R. Fernie, Ute Roessner, Yaniv Semel, Ilse Balbo, Tzili Pleban, Joachim Kopka, Dani Zamir, Amit Gur and Nicolas Schauer. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact